Drawing for NATURA FOTOEQUILIBRIO

USPTO serial 76367765

NATURA FOTOEQUILIBRIO

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MAYERSCHOFF, GLENN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NATURA FOTOEQUILIBRIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JEFFERSON F SCHER

JEFFERSON F SCHER CARR & FERRELL LLP2200 GENG RDPALO ALTO, CA 94303UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003cosmetics; makeup; foundation makeup; body and face powder; eyebrow shadow; eyebrow pencils; lipsticks; lip liner; eye liner; skin lotions; mascara; cosmetic pencils; false eyelashes; preparations and adhesives for false eyelashes; adhesives for cosmetic purposes; lotion for toning and firming the skin; skin whitening cream; sunscreen and sun-tanning preparations; hair pomades for cosmetic purposes; permanent wave preparations; nail polish and varnish; false nails; nail care preparations; hair spray and hair styling preparations; hair waving lotions; tissues impregnated with cosmetic lotions; make-up removing preparations; beauty masks; cosmetic dyes, including hair dyes and hair colorants; cotton sticks, puffs and swabs for cosmetic purposes; cream for the face; milks for cosmetic purposes; bath salts, not for medical purposes; beard dyes; hair color remover; hair bleach; cakes of toilet soaps; facial cleansers and toners; skin cleansers and toners; perfume; toilet water; potpourris; scented wood; eau de cologne; botanical extracts and concentrated perfume for personal use; antiperspirants; personal deodorants; fragrances for personal use; essential oils for personal use; scented oils to produce aromas when heated; bath oil; soap; depilatory wax; shaving preparations and shaving soap; after-shave lotions; shampoos; mouth washes, not for medical purposes; dentifrices; depilatories and depilatory preparationsACTIVE—
005pharmaceutical, herbal and medicinal preparations for the treatment of the following-- the cardiovascular system, namely, chronic venous insufficiency, varices, phlebitis and thrombophlebitis, peripheral vascular insufficiency, the digestive system, namely, hyposecretory dyspepsia, hepatic dyspepsia, cholecystitis not complicated by biliary obstruction, hemorrhoids, the hepatobiliary system, namely, nonspecific dyspepsia, post-hepatitis syndrome, intestinal constipation, the metabolic system, the respiratory system, namely, influenza and colds, respiratory allergies, immunological system, namely, prevention and treatment of respiratory viral infections, prevention or treatment of recurrent vaginal candidiasis, the nervous system, namely, insomnia, anxiety, the urinary system, namely, edema, treatment of urethritis, cystitis, and urinary infection, the cutaneous system, namely, eczema and other soft tissue inflammatory processes, the osteoarticular system, namely, arthritis and arthralgia, treatment of lumbar pain and pain in the sciatic nerve, the female reproductive system, namely, menstrual cramps, premenstrual tension, the male reproductive system, namely, diminished libido, and stress-related physical and mental exhaustion; antiseptics; dental abrasives; mouthwashes for medical purposes; bath salts for medical purposes; medical and pharmaceutical preparations for weight loss and skin care , namely, treatment of eczema and inflammation of the epidermis; smelling salts; preparations to treat soreness from teething; medicinal herbs for the treatment of the following-- the cardiovascular system, namely, chronic venous insufficiency, varices, phlebitis and thrombophlebitis, peripheral vascular insufficiency, the digestive system, namely, hyposecretory dyspepsia, hepatic dyspepsia, cholecystitis not complicated by biliary obstruction, hemorrhoids, the hepatobiliary system, namely, nonspecific dyspepsia, post-hepatitis syndrome, intestinal constipation, the metabolic system, the respiratory system, namely, influenza and colds, respiratory allergies, immunological system, namely, prevention and treatment of respiratory viral infections, prevention or treatment of recurrent vaginal candidiasis, the nervous system, namely, insomnia, anxiety, the urinary system, namely, edema, treatment of urethritis, cystitis, and urinary infection, the cutaneous system, namely, eczema and other soft tissue inflammatory processes, the osteoarticular system, namely, arthritis and arthralgia, treatment of lumbar pain and pain in the sciatic nerve, the female reproductive system, namely, menstrual cramps, premenstrual tension, the male reproductive system, namely, diminished libido, and stress-related physical and mental exhaustion; teas for medicinal purposes; mineral food supplements; meal replacement drinks; meal replacement drink mix; vitamin and mineral supplements; nutritional additives for food; food for medically restricted dietsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 20, 2007MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 20, 2007ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 24, 2006EX5GSOU EXTENSION 5 GRANTED—
Oct 5, 2006EXT5SOU EXTENSION 5 FILED—
Oct 5, 2006EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 20, 2006EX4GSOU EXTENSION 4 GRANTED—
Mar 31, 2006EXT4SOU EXTENSION 4 FILED—
Mar 31, 2006EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 30, 2006CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 30, 2006COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 3, 2005EX3GSOU EXTENSION 3 GRANTED—
Oct 3, 2005EXT3SOU EXTENSION 3 FILED—
Oct 3, 2005EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 4, 2005EX2GSOU EXTENSION 2 GRANTED—
Apr 4, 2005EXT2SOU EXTENSION 2 FILED—
Apr 4, 2005EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 5, 2004EX1GSOU EXTENSION 1 GRANTED—
Oct 8, 2004MAILPAPER RECEIVED—
Oct 5, 2004EXT1SOU EXTENSION 1 FILED—
Jun 23, 2004CFITCASE FILE IN TICRS—
Apr 6, 2004NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 13, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 24, 2003NPUBNOTICE OF PUBLICATION—
Nov 5, 2003TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 30, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 28, 2003CNEAEXAMINERS AMENDMENT MAILED—
May 8, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 10, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 10, 2003MAILPAPER RECEIVED—
Oct 7, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 30, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 30, 2002MAILPAPER RECEIVED—
Feb 27, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 26, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 25, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance